Epanova® for Lowering Very High Triglycerides

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

399

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

March 31, 2012

Study Completion Date

April 30, 2012

Conditions
Severe Hypertriglyceridemia
Interventions
DRUG

placebo

4 capsules (1g) daily for 12 weeks

DRUG

omefas

2 capsules (1g) + 2 placebo daily for 12 weeks

DRUG

omefas

3 capsules (1g) + 1 placebo daily for 12 weeks

DRUG

omefas

4 capsules (1g)daily for 12 weeks

Trial Locations (68)

1062

Budapest

1115

Budapest

1125

Budapest

2100

Copenhagen

2730

Herlev

2820

Gentofte Municipality

3800

Szikszó

3980

Sátoraljaújhely

4032

Debrecen

4043

Debrecen

6500

Baja

8000

Székesfehérvár

8800

Viborg

19104

Philadelphia

19446

Philadelphia

23294

Richmond

23502

Norfolk

27262

High Point

28144

Salisbury

30328

Atlanta

33012

Hialeah

33134

Coral Gables

33169

Miami

33709

St. Petersburg

34461

Summerfield

34471

Ocala

37604

Johnson City

37620

Bristol

37660

Kingsport

38654

Olive Branch

40213

Louisville

43213

Columbus

45212

Cincinnati

45246

Cincinnati

60101

Addison

60654

Chicago

61037

Kharkiv

61039

Kharkiv

61176

Kharkiv

69118

Zaporizhzhya

73103

Oklahoma City

78215

San Antonio

91950

National City

95823

Sacramento

98502

Olympia

129090

Moscow

132001

Karnāl

192288

Saint Petersburg

196084

Saint Petersburg

302015

Jaipur

395007

Surat

411005

Pune

452014

Indore

560003

Bangalore

560043

Banswada

560054

Bangalore

600010

Chennai

630068

Novosibirsk

06040

Manchester

04210

Auburn

Unknown

Bangalore

1105AZ

Amsterdam

9711SG

Groningen

3004BA

Rotterdam

3021HC

Rotterdam

3584CX

Utrecht

03115

Kiev

03680

Kiev

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY